Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Dr Jewett and Dr Kulkarni

<< Previous

Bullboard Posts

Next >>

Comment by Eoganachton Jan 09, 2021 8:10pm

161 Views

Post# 32262222

RE:RE:Dr Jewett and Dr Kulkarni

Thanks for that. It's great to see Drs. Jewett and Kulkarni honoured. Richly deserved.

enriquesuave wrote:
https://twitter.com/pmcancercentre/status/1347292422687043584

enriquesuave wrote: Both got very significant recognition this week. Our team at UHN who are very optimistic about TLD-1433 for NMIBC as seen in last AGM videos.
https://bladdercancercanada.org/en/congratulations-to-dr-michael-a-s-jewett-for-his-appointment-to-the-order-of-canada/